This is due to the low levels of prelamin A expression in the brain (Jung et al., 2012), and to the presence of a tumour protection mechanism mediated by bromodomain containing protein 4 (BRD4) in cells from individuals with HGPS (Fernandez et al., 2014) (discussed in more detail later). The gene discussed is BRD4; the disease is neoplasm.